The CardioMetaboliQ Labs DBS Test and Report integrates traditional cardiometabolic test markers with advanced indexes including Fatty Liver Index, Triglyceride-Glucose Index, Residual Atherogenic Risk and Anthropometric Insulin Resistance. Test results are presented in a comprehensive and concise report, CardioMetaboliQ boosts patient engagement and awareness, and improves wellness outcomes.
Functional Medicine practitioners rely on testing that efficiently educates and motivates patients. By focusing on root cause and the interconnected nature of cardiometabolic health, CardioMetaboliQ provides a useful and efficient tool to the functional practitioner.
Webinar Highlights:
• The Elephant in the Room: Cardiometabolic Disease
• What's Missing in Cardiometabolic Testing?
• Why Fatty Liver Index is Critical
• Optimal Indexes/Markers for Cardiometabolic Testing
• Testing as a Practice Growth Tool
• Patient Engagement & Motivation: Action and Tracking
• Using the 30,000 Foot View
The CardioMetaboliQ Test and Report are hybridized for use in the Upfront Labs practice model. Using enhanced reporting and engagement tools, it also facilitates new patient acquisition and group treatment processes keeping the practitioner in the central role while reducing process friction to allow for a more efficient therapeutic process.
Speaker: Steven Bennett DC, President & Founder CardioMetaboliQ Labs LLC
